This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (225)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

A Report From the Boston Collaborative Drug Surveillance Program on 15 438 Consecutive Inpatients, 1975 to 1982

Michael Bigby, MD; Susan Jick, MPH; Hershel Jick, MD; Kenneth Arndt, MD

JAMA. 1986;256(24):3358-3363.

Abstract
We analyzed the data on 15 438 consecutive medical inpatients monitored by the Boston Collaborative Drug Surveillance Program from June 1975 to June 1982 to determine the rates of allergic cutaneous reactions to drugs introduced since 1975 and to confirm and extend findings from an earlier study of the preceding 22 227 patients. There were 358 reactions occurring in 347 patients, for an overall reaction rate among patients of 2.2%. Each patient received a mean of eight different drugs. Rashes were attributed to 51 drugs, and 75% of the allergic cutaneous reactions were attributed to antibiotics, blood products, and inhaled mucolytics. Amoxicillin (51.4 reactions per 1000 patients exposed), trimethoprim-sulfamethoxazole (33.8/1000), and ampicillin (33.2/1000) had the highest reaction rates. Drug-specific reaction rates ranged from zero to 51.4 per 1000 and were determined for 180 drugs or drug groups. These results provide physicians with quantitative data that will be helpful in clinical decision making when drug-induced exanthems, urticaria, or generalized pruritus occurs.

(JAMA 1986;256:3358-3363)

Author Affiliations
From the Department of Dermatology and the Charles A. Dana Research Institute, Beth Israel Hospital and Harvard Medical School, Boston (Drs Bigby and Arndt); and the Department of Medicine, Boston Collaborative Drug Surveillance Program, Boston University Medical Center (Dr Jick and Ms Jick).

Footnotes
Reprint requests to Department of Dermatology, Beth Israel Hospital, 330 Brookline Ave, Boston, MA 02215 (Dr Bigby).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

DRESS Syndrome: A Practical Approach for Primary Care Practitioners
Seth et al.
CLIN PEDIATR 2008;47:947-952.
 

Cutaneous Reactions to Drugs in Children
Segal et al.
Pediatrics 2007;120:e1082-e1096.
ABSTRACT | FULL TEXT  

Aminopenicillin-induced exanthema allows treatment with certain cephalosporins or phenoxymethyl penicillin
Trcka et al.
J Antimicrob Chemother 2007;60:107-111.
ABSTRACT | FULL TEXT  

Comparison and predictors of rash associated with 15 antiepileptic drugs
Arif et al.
Neurology 2007;68:1701-1709.
ABSTRACT | FULL TEXT  

Anaesthetist's responses to patients' self-reported drug allergies
MacPherson et al.
Br J Anaesth 2006;97:634-639.
ABSTRACT | FULL TEXT  

Pharmacogenetics, Drug-Metabolizing Enzymes, and Clinical Practice
Gardiner and Begg
Pharmacol. Rev. 2006;58:521-590.
ABSTRACT | FULL TEXT  

Antibiotic Allergy
Gruchalla and Pirmohamed
NEJM 2006;354:601-609.
FULL TEXT  

Not All Sulfa Drugs Are Created Equal
Toler and Rodriguez
The Annals of Pharmacotherapy 2004;38:2166-2167.
FULL TEXT  

ORAL ADVERSE DRUG REACTIONS TO CARDIOVASCULAR DRUGS
Torpet et al.
CROBM 2004;15:28-46.
ABSTRACT | FULL TEXT  

Absence of Cross-Reactivity between Sulfonamide Antibiotics and Sulfonamide Nonantibiotics
Strom et al.
NEJM 2003;349:1628-1635.
ABSTRACT | FULL TEXT  

Delayed Drug Hypersensitivity Reactions
Pichler
ANN INTERN MED 2003;139:683-693.
ABSTRACT | FULL TEXT  

Medication Errors: An Analysis Comparing PHICO's Closed Claims Data and PHICO's Event Reporting Trending System (PERTS)
Benjamin and Pendrak
J Clin Pharmacol 2003;43:754-759.
ABSTRACT | FULL TEXT  

Cutaneous Drug Reactions
Svensson et al.
Pharmacol. Rev. 2001;53:357-379.
ABSTRACT | FULL TEXT  

Antibiotics before dental procedures for endocarditis prophylaxis: back to the future
MORRIS and WEBB
Heart 2001;86:3-4.
FULL TEXT  

Rates of Cutaneous Reactions to Drugs
Bigby
Arch Dermatol 2001;137:765-770.
ABSTRACT | FULL TEXT  

Inpatient Adverse Cutaneous Drug Eruptions and Eosinophilia
Romagosa et al.
Arch Dermatol 2001;137:511-512.
FULL TEXT  

Antibiotic Rashes in Children: A Survey in a Private Practice Setting
Ibia et al.
Arch Dermatol 2000;136:849-854.
ABSTRACT | FULL TEXT  

Improving the Outcome of Patients With Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome
Stern
Arch Dermatol 2000;136:410-411.
FULL TEXT  

Allergy to beta -Lactam Antibiotics in Children
Ponvert et al.
Pediatrics 1999;104:45e-45.
ABSTRACT | FULL TEXT  

Allergic Reactions to Drugs and Biologic Agents
deShazo and Kemp
JAMA 1997;278:1895-1906.
ABSTRACT  

Ampicillin-Specific Rashes
Adcock and Rodman
Arch Fam Med 1996;5:301-304.
ABSTRACT  

Selective Causes of Fever in Adult Human Immunodeficiency Virus--Infected Patients Relative to CD4+ Cell Counts
Czachor and Gleckman
Arch Fam Med 1995;4:879-884.
ABSTRACT  

Metabolic Predisposition to Cutaneous Adverse Drug Reactions: Role in Toxic Epidermal Necrolysis Caused by Sulfonamides and Anticonvulsants
Wolkenstein et al.
Arch Dermatol 1995;131:544-551.
ABSTRACT  

Severe Adverse Cutaneous Reactions to Drugs
Roujeau and Stern
NEJM 1994;331:1272-1285.
FULL TEXT  

Drug Rashes: What Are the Targets of Cell-Mediated Cytotoxicity?
Chosidow et al.
Arch Dermatol 1994;130:627-629.
ABSTRACT  

Cutaneous Disease and Drug Reactions in HIV Infection
Coopman et al.
NEJM 1993;328:1670-1674.
ABSTRACT | FULL TEXT  

Dermatologic Adverse Drug Reactions in a Family Medicine Setting
Ives et al.
Arch Fam Med 1992;1:241-245.
ABSTRACT  

Acute Generalized Exanthematous Pustulosis: Analysis of 63 Cases
Roujeau et al.
Arch Dermatol 1991;127:1333-1338.
ABSTRACT  

Allergic Reactions to Drugs and Biologic Agents
Anderson and Adkinson
JAMA 1987;258:2891-2899.
ABSTRACT